We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GXGX market cap is 1.47B. The company's latest EPS is USD 0.0982 and P/E is 103.87.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.14M | 4.13M | 3.94M | 2.94M | 3.79M |
| Operating Income | -38.89M | -35.35M | -82.8M | -127.88M | -123.17M |
| Net Income | 4.78M | 24.43M | -64.02M | -47.95M | -93.88M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 21.34M | 17.98M |
| Operating Income | -1,000 | -564k | -4.22M | -150.2M | -151.88M |
| Net Income | -1,000 | 2.51M | -2.63M | -100.12M | 14.19M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 437.12M | 401.07M | 362.42M | 246.42M | 157.19M |
| Total Liabilities | 272.88M | 202.17M | 206.79M | 127.92M | 126.95M |
| Total Equity | 164.24M | 198.9M | 155.63M | 118.5M | 30.25M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 174k | 291.61M | 292.16M | 414.13M | 401.07M |
| Total Liabilities | 150k | 11.04M | 14.22M | 314.71M | 202.17M |
| Total Equity | 24k | 5M | 5M | 99.42M | 198.9M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -108.29M | -137.88M | -15M | -26.02M | -34.34M |
| Investing | -4.46M | -5.24M | -3.21M | -3.24M | -3.47M |
| Financing | 118.15M | 119.84M | 12.76M | 18.37M | 24.11M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | N/A | -1.1M | -1.18M | -110.1M | -137.88M |
| Investing | N/A | -286.85M | 579k | -5.9M | -5.24M |
| Financing | 25k | 288.84M | N/A | 98.56M | 119.84M |
| Market Cap | 1.47B |
| Price to Earnings Ratio | 103.87 |
| Price to Sales Ratio | 81.99 |
| Price to Cash Ratio | 105.59 |
| Price to Book Ratio | 7.41 |
| Dividend Yield | - |
| Shares Outstanding | 144.52M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.1 (0.97%) |
| Company Name | GX Acquisition Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.celularity.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
